EHC (Encompass Health Corporation Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by EHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | John Patrick Darby | EVP, Gen Counsel & Secretary | MIXED | — | — |
| 2026-09-01 | Andrew L Price | Chief Accounting Officer | Sell | — | — |
| 2026-08-11 | DOUGLAS E COLTHARP | EVP & Chief Financial Officer | Sell | — | — |
| 2026-08-11 | Mark J Tarr | President & CEO | Sell | — | — |
| 2026-08-11 | John Patrick Darby | EVP, Gen Counsel & Secretary | Sell | — | — |
| 2026-07-16 | Kevin J. O'Connor | Director | A | — | — |
| 2026-07-16 | Terrance Williams | Director | A | — | — |
| 2026-07-16 | NANCY M SCHLICHTING | Director | A | — | — |
| 2026-07-16 | LESLYE G KATZ | Director | A | — | — |
| 2026-07-16 | GREG D CARMICHAEL | Director | A | — | — |
| 2026-07-16 | Christopher R Reidy | Director | A | — | — |
| 2026-07-16 | Cain A Hayes | Director | A | — | — |
| 2026-07-16 | JOAN E HERMAN | Director | A | — | — |
| 2026-07-16 | Edward M Christie III | Director | A | — | — |
| 2026-05-18 | DOUGLAS E COLTHARP | EVP & Chief Financial Officer | MIXED | — | — |
| 2026-05-12 | Patrick William Tuer | EVP, Chief Operating Officer | Sell | — | — |
| 2026-05-11 | NANCY M SCHLICHTING | Director | A | — | — |
| 2026-05-11 | JOAN E HERMAN | Director | A | — | — |
| 2026-05-11 | LESLYE G KATZ | Director | A | — | — |
| 2026-05-11 | Terrance Williams | Director | A | — | — |
| 2026-05-11 | GREG D CARMICHAEL | Director | A | — | — |
| 2026-05-11 | Cain A Hayes | Director | A | — | — |
| 2026-05-11 | Christopher R Reidy | Director | A | — | — |
| 2026-05-11 | Edward M Christie III | Director | A | — | — |
| 2026-05-11 | Kevin J. O'Connor | Director | A | — | — |
| 2026-04-16 | Terrance Williams | Director | A | — | — |
| 2026-04-16 | NANCY M SCHLICHTING | Director | A | — | — |
| 2026-04-16 | Christopher R Reidy | Director | A | — | — |
| 2026-04-16 | Kevin J. O'Connor | Director | A | — | — |
| 2026-04-16 | LESLYE G KATZ | Director | A | — | — |
| 2026-04-16 | JOAN E HERMAN | Director | A | — | — |
| 2026-04-16 | Cain A Hayes | Director | A | — | — |
| 2026-04-16 | Edward M Christie III | Director | A | — | — |
| 2026-04-16 | GREG D CARMICHAEL | Director | A | — | — |
| 2026-03-10 | Edmund Fay | Sr. Vice Pres. and Treasurer | MIXED | — | — |
| 2026-03-03 | DOUGLAS E COLTHARP | EVP & Chief Financial Officer | F | — | — |
| 2026-03-03 | Patrick William Tuer | EVP, Chief Operating Officer | F | — | — |
| 2026-03-03 | Mark J Tarr | President & CEO | F | — | — |
| 2026-03-03 | John Patrick Darby | EVP, Gen Counsel & Secretary | F | — | — |
| 2026-03-03 | Elissa Joy Charbonneau | Chief Medical Officer | F | — | — |
| 2026-03-03 | Edmund Fay | Sr. Vice Pres. and Treasurer | F | — | — |
| 2026-03-03 | Andrew L Price | Chief Accounting Officer | F | — | — |
| 2026-02-25 | John Patrick Darby | EVP, Gen Counsel & Secretary | F | — | — |
| 2026-02-25 | Elissa Joy Charbonneau | Chief Medical Officer | F | — | — |
| 2026-02-25 | Andrew L Price | Chief Accounting Officer | F | — | — |
| 2026-02-25 | DOUGLAS E COLTHARP | EVP & Chief Financial Officer | F | — | — |
| 2026-02-25 | Patrick William Tuer | EVP, Chief Operating Officer | F | — | — |
| 2026-02-25 | Edmund Fay | Sr. Vice Pres. and Treasurer | F | — | — |
| 2026-02-25 | Mark J Tarr | President & CEO | F | — | — |
| 2026-02-23 | Patrick William Tuer | EVP, Chief Operating Officer | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | CEO & President, Home Health | 724,111 | — |
| — | President & CEO | 267,814 | — |
| — | Director | 162,592 | — |
| — | Director | 99,938 | — |
| — | Director | 99,325 | — |
| — | Sr. Vice Pres. and Treasurer | 89,325 | — |
| — | Director | 82,981 | — |
| — | Director | 81,254 | — |
| — | Director | 80,391 | — |
| — | Director | 78,458 | — |
| — | EVP & Chief Financial Officer | 77,988 | — |
| — | EVP, Gen Counsel & Secretary | 75,041 | — |
| — | Chief Accounting Officer | 69,483 | — |
| — | President & CEO, HHH | 59,539 | — |
| — | Director | 49,643 | — |
| — | Director | 49,643 | — |
| — | Chief Human Resources Officer | 41,732 | — |
| — | EVP, Chief Operating Officer | 24,755 | — |
| — | Director | 22,972 | — |
| — | Director | 20,349 | — |
| — | Chief Medical Officer | 17,644 | — |
| — | Director | 17,458 | — |
| — | Director | 16,859 | — |
| — | Director | 14,764 | — |
| — | Director | 11,582 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EHC quote page; the site-wide leaderboard is on the insider transactions hub.